SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS; A HIGH NUMBER OF PATIENTS ACHIEVE DOPPLER REMISSION AFTER 24 WEEKS

被引：0
|
作者：
Hammer, H. B. [1 ]
Hansen, I. M. J. [2 ]
Jarvinen, P. [3 ]
Leirisalo-Repo, M. [4 ,5 ]
Ziegelasch, M. [6 ]
Agular, B. [7 ]
Terslev, L. [8 ]
机构：
[1] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway
[2] Svendborg Hosp, Dept Rheumatol, Svendborg, Denmark
[3] Kiljavan Laaketutkimus, Dept Rheumatol, Kiljavan, Finland
[4] Helsinki Univ Hosp, Dept Rheumatol, Helsinki, Finland
[5] Univ Helsinki, Helsinki, Finland
[6] Univ Hosp, Dept Rheumatol, Linkoping, Sweden
[7] Roche, Dept Med, Copenhagen, Denmark
[8] Copenhagen Univ Hosp Glostrup, Ctr Rheumatol & Spinal Dis, Copenhagen, Denmark
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.3533
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0200
引用
收藏
页码：319 / 319
页数：1
相关论文
共 50 条
  • [41] THE IMPROVEMENT OF ULTRASONOGRAPHIC FINDINGS FOR 24 WEEKS MAY PREDICT REMISSION AT 52 WEEKS IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS TREATED WITH IGURATIMOD THERAPY
    Kanayama, Y.
    Nagasaka, H.
    Shimotake, M.
    Miyachi, F.
    Fujita, K.
    Nagata, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 284 - 285
  • [42] COMORBIDITY AND OBESITY ARE INDEPENDENTLY ASSOCIATED WITH FAILURE TO ACHIEVE REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Ellerby, Nicholas
    Mattey, Derek L.
    Packham, Jonathan
    Dawes, Peter
    Hider, Samantha L.
    RHEUMATOLOGY, 2013, 52 : 71 - 71
  • [43] PREDICTABILITY TO ACHIEVE LOW ACTIVITY AND/OR REMISSION WITH LEFLUNOMIDE USE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Fabricio, E. -O.
    Sifuentes, C.
    Mariana, M.
    Arce-Salinas, C. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 261 - 261
  • [44] REMISSION ON THE BASIS OF SELF-ASSESSMENT TOOLS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMAB
    Starkova, A.
    Amirdjanova, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 969 - 969
  • [45] IS THERE A POTENTIAL FOR THERAPEUTIC DRUG MONITORING OF SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN DAILY PRACTICE?
    Layegh, Z.
    L'Ami, M. J.
    Bastida, C.
    Huitema, A. D.
    Krieckaert, C.
    Nurmohamed, M. T.
    Rispens, T.
    Wolbink, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 966 - 966
  • [46] Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis
    Ogata, Atsushi
    Atsumi, Tatsuya
    Fukuda, Takaaki
    Hirabayashi, Yasuhiko
    Inaba, Masaaki
    Ishiguro, Naoki
    Kai, Motokazu
    Kawabata, Daisuke
    Kida, Daihei
    Kohsaka, Hitoshi
    Matsumura, Ryutaro
    Minota, Seiji
    Mukai, Masaya
    Sumida, Takayuki
    Takasugi, Kiyoshi
    Tamaki, Shigenori
    Takeuchi, Tsutomu
    Ueda, Atsuhisa
    Yamamoto, Kazuhiko
    Yamanaka, Hisashi
    Yoshifuji, Hajime
    Nomura, Akira
    ARTHRITIS CARE & RESEARCH, 2015, 67 (10) : 1354 - 1362
  • [47] Real World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis
    Punekar, Rajeshwari
    Choi, Jeannie
    Boklage, Susan
    Iglesias-Rodriguez, Melitza
    Nola, Kamala
    AMERICAN HEALTH AND DRUG BENEFITS, 2019, 12 (08): : 400 - 409
  • [48] What Factors Lead To Achieve and Sustain Remission In Rheumatoid Arthritis Patients With Moderate To High Disease Activity?
    Cho, Soo-Kyung
    Sung, Yoon-Kyoung
    Shim, Jeeseon
    Choi, Chan-Bum
    Choe, Jung-Yoon
    Chung, Won Tae
    Hong, Seung-Jae
    Jun, Jae-Bum
    Kim, Tae-Hwan
    Kim, Tae-Jong
    Koh, Eun-Mi
    Lee, Jisoo
    Lee, Shin-Seok
    Lee, Sung Won
    Yoo, Dae-Hyun
    Bae, Sang-Cheol
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S572 - S572
  • [49] Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice
    Nakashima, Yasuharu
    Kondo, Masakazu
    Shono, Eisuke
    Ishinishi, Takashi
    Tsukamoto, Hiroshi
    Kuroda, Koji
    Maeyama, Akira
    Harada, Hiroshi
    Maekawa, Masayuki
    Shimauchi, Takashi
    Nagamine, Ryuji
    Jojima, Hiroshi
    Yoshizawa, Seiji
    Tsuru, Tomomi
    Otsuka, Takeshi
    Miyahara, Hisaaki
    Suematsu, Eiichi
    Wada, Ken
    Yoshizawa, Shigeru
    Inoue, Yasushi
    Fukuda, Takaaki
    Ikemura, Satoshi
    Haraguchi, Akihisa
    MODERN RHEUMATOLOGY, 2020, 30 (05) : 807 - 815
  • [50] Remission of Rheumatoid Arthritis and Primary Biliary Cholangitis After Treatment With Tocilizumab
    Azevedo, Soraia
    Sousa-Neves, Joana
    Rodrigues, Joana Ramos
    Peixoto, Daniela
    Tavares-Costa, Jose
    Teixeira, Filipa
    REUMATOLOGIA CLINICA, 2021, 17 (06): : 364 - 365
12345